ReviewCurrent treatment options in oncology2023
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer.
Oluwadunni E Emiloju et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it